Abstract

Many thousands of urinary tract infections (UTIs) are linked to the insertion of an indwelling urethral catheter (Saint et al 2000). Catheterisation is often prolonged unnecessarily (Saint et al 2002), thereby increasing the infection risk. In this audit of 133 medical and surgical patients who were catheterised in an acute NHS hospital trust, the potential of a new silver alloy hydrogel-coated catheter to reduce the rate of infection was demonstrated. Benefits were indicated in terms of reducing clinical risk to the patient and the financial costs associated with treating catheter-associated UTIs, representing a substantial cost saving for the NHS.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.